Japan · Delayed Price · Currency is JPY Kohjin Bio Statistics
Total Valuation
Kohjin Bio has a market cap or net worth of JPY 6.14 billion. The enterprise value is 5.51 billion.
| Market Cap | 6.14B |
| Enterprise Value | 5.51B |
Important Dates
The next estimated earnings date is Friday, February 13, 2026.
| Earnings Date | Feb 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Kohjin Bio has 5.11 million shares outstanding. The number of shares has increased by 22.72% in one year.
| Current Share Class | 5.11M |
| Shares Outstanding | 5.11M |
| Shares Change (YoY) | +22.72% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 55.34% |
| Owned by Institutions (%) | 16.65% |
| Float | 1.54M |
Valuation Ratios
The trailing PE ratio is 8.55.
| PE Ratio | 8.55 |
| Forward PE | n/a |
| PS Ratio | 1.18 |
| PB Ratio | 1.06 |
| P/TBV Ratio | 1.06 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 10.27 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.13, with an EV/FCF ratio of -17.43.
| EV / Earnings | 7.66 |
| EV / Sales | 1.06 |
| EV / EBITDA | 4.13 |
| EV / EBIT | 5.75 |
| EV / FCF | -17.43 |
Financial Position
The company has a current ratio of 1.99, with a Debt / Equity ratio of 0.34.
| Current Ratio | 1.99 |
| Quick Ratio | 1.54 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | 1.56 |
| Debt / FCF | -6.17 |
| Interest Coverage | 24.83 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 13.89% |
| Return on Capital Employed (ROCE) | 13.35% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 31.16M |
| Profits Per Employee | 4.31M |
| Employee Count | 167 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Kohjin Bio has paid 202.00 million in taxes.
| Income Tax | 202.00M |
| Effective Tax Rate | 21.93% |
Stock Price Statistics
The stock price has decreased by -20.56% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -20.56% |
| 50-Day Moving Average | 1,440.62 |
| 200-Day Moving Average | 1,602.44 |
| Relative Strength Index (RSI) | 17.26 |
| Average Volume (20 Days) | 7,310 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Kohjin Bio had revenue of JPY 5.20 billion and earned 719.00 million in profits. Earnings per share was 140.67.
| Revenue | 5.20B |
| Gross Profit | 2.32B |
| Operating Income | 869.00M |
| Pretax Income | 921.00M |
| Net Income | 719.00M |
| EBITDA | 1.25B |
| EBIT | 869.00M |
| Earnings Per Share (EPS) | 140.67 |
Balance Sheet
The company has 2.59 billion in cash and 1.95 billion in debt, with a net cash position of 637.00 million or 124.62 per share.
| Cash & Cash Equivalents | 2.59B |
| Total Debt | 1.95B |
| Net Cash | 637.00M |
| Net Cash Per Share | 124.62 |
| Equity (Book Value) | 5.81B |
| Book Value Per Share | 1,137.02 |
| Working Capital | 2.30B |
Cash Flow
In the last 12 months, operating cash flow was 598.00 million and capital expenditures -914.00 million, giving a free cash flow of -316.00 million.
| Operating Cash Flow | 598.00M |
| Capital Expenditures | -914.00M |
| Free Cash Flow | -316.00M |
| FCF Per Share | -61.82 |
Margins
Gross margin is 44.55%, with operating and profit margins of 16.70% and 13.82%.
| Gross Margin | 44.55% |
| Operating Margin | 16.70% |
| Pretax Margin | 17.70% |
| Profit Margin | 13.82% |
| EBITDA Margin | 23.97% |
| EBIT Margin | 16.70% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 25.00, which amounts to a dividend yield of 2.05%.
| Dividend Per Share | 25.00 |
| Dividend Yield | 2.05% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 16.69% |
| Buyback Yield | -22.72% |
| Shareholder Yield | -20.64% |
| Earnings Yield | 11.70% |
| FCF Yield | -5.14% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Kohjin Bio has an Altman Z-Score of 3.47 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.47 |
| Piotroski F-Score | 5 |